China To Awaken RMB 100 Billion Pharma Giant In 2011-15
This article was originally published in PharmAsia News
Executive Summary
China's 12 Five Year Plan for the pharmaceutical industry, to be unveiled after the annual sessions of NPC and CPPCC, will center on encouraging mergers and acquisitions in the industry, aiming to have one to two RMB 100 billion-scale national pharmaceutical giants and 20 RMB 10 billion regional drug giants by 2015, Vice Commerce Minister Jiang Zengwei revealed at the CPPCC annual session March 10
|
China's 12 Five Year Plan for the pharmaceutical industry, to be unveiled after the annual sessions of NPC and CPPCC, will center on encouraging mergers and acquisitions in the industry, aiming to have one to two RMB 100 billion-scale national pharmaceutical giants and 20 RMB 10 billion regional drug giants by 2015, Vice Commerce Minister Jiang Zengwei revealed at the CPPCC annual session March 10. The plan will also address some of the industry's existing common malpractices, such as doctors' recommendations according to drug prices and benefit offers to hospital staff to boost sales. The pharmaceutical M&A buzzing in China began last year, headed by drug giants like China Resources Medications. (Click Here For More - Chinese Language) "12 Five-Year Plan For Pharma Sector Coming Out; Drug Giants To Be Nurtured"- info.pharmacy.hc360.com (3/14/2011) |